Aquestive Therapeutics, Inc. (AQST)
4.05
+0.03
(+0.75%)
USD |
NASDAQ |
Mar 19, 10:39
Aquestive Therapeutics Profit Margin (Quarterly) : -244.8% for Dec. 31, 2025
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Insmed, Inc. | -124.5% |
| Merck & Co., Inc. | 18.15% |
| Verastem, Inc. | -187.7% |
| Harrow, Inc. | 7.44% |
| Beta Bionics, Inc. | -41.92% |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -67.23% |
| Return on Invested Capital | -104.3% |
| Gross Profit Margin (Quarterly) | 55.16% |
| Operating Margin (Quarterly) | -221.6% |
| Return on Net Operating Assets | -350.7% |